Certified by Founder Lodge
ARCH Venture Partners
United States - Chicago, IL
INVESTOR
1 Disclosed Funding Rounds $261,000,000
306 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Early stage venture firm focused on life science discoveries to prevent, detect and cure disease.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 04 ,2024 | Series C | Undisclosed Amount |
| Company | Date | Round | Raised |
|---|---|---|---|
 Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
 OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
 Happy Health |
August, 24 ,2022 | Series A | $60,000,000 |
 Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
 Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
 Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
 Colossal Biosciences |
March, 09 ,2022 | Series A | $60,000,000 |
 Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
 Rapport Therapeutics |
March, 08 ,2023 | Series A | $100,000,000 |
 Treeline Biosciences |
October, 18 ,2022 | Series A | $261,000,000 |
 Homeward |
August, 03 ,2022 | Series B | $50,000,000 |
| Happy Health |
August, 24 ,2022 | Series A | $60,000,000 |
 Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
 Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
 Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
| OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
| Homeward |
August, 03 ,2022 | Series B | $50,000,000 |
 HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
 AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
 Volastra Therapeutics |
March, 08 ,2023 | Series A | $60,000,000 |
 Neumora |
October, 17 ,2022 | Series B | $112,000,000 |
 Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
 Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
 Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
| Rapport Therapeutics |
March, 08 ,2023 | Series A | $100,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Colossal Biosciences |
March, 09 ,2022 | Series A | $60,000,000 |
| Happy Health |
August, 24 ,2022 | Series A | $60,000,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
| Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
| Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
| Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
| Rapport Therapeutics |
March, 08 ,2023 | Series A | $100,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| Homeward |
August, 03 ,2022 | Series B | $50,000,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
 Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
| Volastra Therapeutics |
March, 08 ,2023 | Series A | $60,000,000 |
| OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
| Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
| AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| Volastra Therapeutics |
March, 08 ,2023 | Series A | $60,000,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Colossal Biosciences |
March, 09 ,2022 | Series A | $60,000,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
 Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
| Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| Rapport Therapeutics |
March, 08 ,2023 | Series A | $100,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| Colossal Biosciences |
March, 09 ,2022 | Series A | $60,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
| OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
| Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
| Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
 Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
| Volastra Therapeutics |
March, 08 ,2023 | Series A | $60,000,000 |
| Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
| Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
| Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
 Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| Colossal Biosciences |
March, 09 ,2022 | Series A | $60,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
| AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
 Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
| Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
| Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
| Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
 Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
 eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| ARCH Venture Partners |
September, 04 ,2024 | Series C | Undisclosed Amount |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
 Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
| Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
 Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| AIRNA |
September, 20 ,2023 | Unknown | $30,000,000 |
| ARCH Venture Partners |
September, 04 ,2024 | Series C | Undisclosed Amount |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
| ARCH Venture Partners |
September, 04 ,2024 | Series C | Undisclosed Amount |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
| Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
| Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| ARCH Venture Partners |
September, 04 ,2024 | Series C | Undisclosed Amount |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| Basking Biosciences Inc |
February, 02 ,2024 | Unknown | $55,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Proniras Corporation |
February, 02 ,2024 | Series B | $4,650,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| Moonwalk Biosciences |
January, 08 ,2024 | Series A | $57,000,000 |
| Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
